Xtant Medical Holdings Inc. and its subsidiary, Surgalign SPV, Inc., have completed the sale of certain assets related to their Coflex and CoFix products to Companion Spine, LLC and Companion Spine SAS for a total purchase price of $17.5 million, subject to a closing inventory valuation adjustment. Of this amount, $8.2 million was paid through an unsecured promissory note issued by Companion Spine, with the maturity date of the note extended from January 15, 2026 to January 31, 2026. In a related transaction, Xtant Medical Holdings Inc. also completed the sale of Paradigm Spine GmbH, its wholly owned subsidiary operating outside the United States, to Companion Spine SAS for $1.7 million, with the timing for payment of an estimated positive purchase price adjustment of $1,742,000 also deferred to January 31, 2026. Any downward adjustments to the purchase prices will reduce the principal amount of the promissory note.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtant Medical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-002569), on January 16, 2026, and is solely responsible for the information contained therein.